Monoclonal Antibodies and Multifunctional Cytochrome P450: Drug Metabolism as Paradigm
- 8 March 2006
- journal article
- review article
- Published by Wiley in The Journal of Clinical Pharmacology
- Vol. 46 (3), 353-372
- https://doi.org/10.1177/0091270005285200
Abstract
Monoclonal antibodies are reagents par excellence for analyzing the role of individual cytochrome P450 isoforms in multifunctional biological activities catalyzed by cytochrome P450 enzymes. The precision and utility of the monoclonal antibodies have heretofore been applied primarily to studies of human drug metabolism. The unique and precise specificity and high inhibitory activity toward individual cytochrome P450s make the monoclonal antibodies extraordinary tools for identifying and quantifying the role of each P450 isoform in the metabolism of a drug or nondrug xenobiotic. The monoclonal antibodies identify drugs metabolized by individual, several, or polymorphic P450s. A comprehensive collection of monoclonal antibodies has been isolated to human P450s: 1A1, 1A2, 2A6, 2B6, 2C8, 2C9, 2C family, 2C19, 2D6, 2E1, 3A4/5, and 2J2. The monoclonal antibodies can also be used for identifying drugs and/or metabolites useful as markers for in vivo phenotyping. Clinical identification of a patient's phenotype, coupled with precise knowledge of a drug's metabolism, should lead to a reduction of adverse drug reactions and improved drug therapeutics, thereby promoting advances in drug discovery.Keywords
This publication has 40 references indexed in Scilit:
- Cytochrome P450 3A and 2B6 in the developing kidney: implications for ifosfamide nephrotoxicityPediatric Nephrology, 2005
- THE INVOLVEMENT OF CYP3A4 AND CYP2C9 IN THE METABOLISM OF 17α-ETHINYLESTRADIOLDrug Metabolism and Disposition, 2004
- CYP2C subfamily, primarily CYP2C9, catalyses the enantioselective demethylation of the endocrine disruptor pesticide methoxychlor in human liver microsomes: use of inhibitory monoclonal antibodies in P450 identificationXenobiotica, 2004
- A comparison of relative abundance, activity factor and inhibitory monoclonal antibody approaches in the characterization of human CYP enzymologyBritish Journal of Clinical Pharmacology, 2003
- An inhibitory monoclonal antibody to human cytochrome P450 that specifically binds and inhibits P4502C9II, an allelic variant of P4502C9 having a single amino acid change Arg144 CysXenobiotica, 2000
- Inhibitory and Noninhibitory Monoclonal Antibodies to Human Cytochrome P450 2E1Chemical Research in Toxicology, 1996
- Distribution of cytochrome CYP2E1 in murine liver after ethanol and acetone administrationCarcinogenesis: Integrative Cancer Research, 1991
- Covalent binding to DNA and mutagenicity of 2,4-diaminotoluene metabolites produced by isolated hepatocytes and 9000 g supernatant from Fischer 344 ratsCarcinogenesis: Integrative Cancer Research, 1987
- Monoclonal antibodies to rabbit liver cytochrome P450 LM2FEBS Letters, 1980
- Benzo[ a ]pyrene Diol Epoxides: Mechanism of Enzymatic Formation and Optically Active IntermediatesScience, 1977